Defence Therapeutics Inc. Stock
Stocks
DTC
CA24463V1013
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3900 CAD | 0.00% |
|
+6.85% | -45.83% |
| Market Cap | 33.35M 23.8M 20.67M 19.2M 17.7M 2.27B 33.95M 227M 88.98M 1.13B 89.37M 87.41M 3.79B | P/E 2024 |
-2.5x | P/E 2025 | -9.9x |
|---|---|---|---|---|---|
| Enterprise Value | 33.62M 23.99M 20.84M 19.35M 17.85M 2.29B 34.23M 229M 89.71M 1.14B 90.1M 88.13M 3.83B | EV / Sales 2024 |
-
| EV / Sales 2025 | - |
| Free-Float |
66.13% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 week | +6.85% | ||
| Current month | -11.36% | ||
| 1 month | -11.36% | ||
| 3 months | -31.58% | ||
| 6 months | -29.09% | ||
| Current year | -45.83% |
| 1 week | 0.38 |  | 0.42 |
| 1 month | 0.36 | | 0.5 |
| Current year | 0.36 | | 0.74 |
| 1 year | 0.36 | | 0.93 |
| 3 years | 0.36 | | 3.04 |
| 5 years | 0.36 | | 8.15 |
| 10 years | 0.36 | | 8.15 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 53 | 27/09/2024 | |
Arnab De
DFI | Director of Finance/CFO | 55 | 20/12/2024 |
Maxime Parisotto
CTO | Chief Tech/Sci/R&D Officer | - | 25/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
John Lambert
BRD | Director/Board Member | 74 | 01/06/2026 |
| Director/Board Member | 53 | 02/06/2020 | |
| Director/Board Member | 64 | 05/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 16/12/25 | Option | Director | 50,000 | 0.0914% | ||
| 16/12/25 | Other | Director | 0 | 0% | ||
| 16/12/25 | Option | Director | 50,000 | 0.0914% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +6.85% | -37.10% | -86.32% | 21.09M | |
| +0.49% | +4.49% | +0.10% | +13.34% | 49.37B | |
| -3.95% | +14.70% | +24.15% | +5.15% | 39.14B | |
| +6.22% | +1.81% | +419.17% | +647.45% | 40.85B | |
| -1.57% | -1.44% | +7.38% | +43.06% | 35.81B | |
| +5.56% | +11.70% | +11.64% | +51.50% | 30.5B | |
| -0.39% | -0.63% | - | - | 16.55B | |
| -1.13% | -4.54% | +32.10% | +126.95% | 16.14B | |
| -7.10% | -2.81% | -8.80% | -34.35% | 12.77B | |
| +0.29% | +3.61% | +2.20% | +9.94% | 13.71B | |
| Average | +0.19% | +6.12% | +50.09% | +86.30% | 25.49B | |
| Weighted average by Cap. | +1.02% | +7.02% | +80.27% | +134.98% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | - | - |
| Net income | -13.19M -9.42M -8.18M -7.59M -7M -899M -13.43M -89.91M -35.2M -446M -35.36M -34.58M -1.5B | -3.52M -2.51M -2.18M -2.03M -1.87M -240M -3.59M -24M -9.4M -119M -9.44M -9.23M -401M |
| Net Debt | 1.69M 1.21M 1.05M 973K 897K 115M 1.72M 11.52M 4.51M 57.18M 4.53M 4.43M 192M | 272K 194K 169K 156K 144K 18.52M 277K 1.85M 725K 9.2M 729K 713K 30.93M |
Employees
-
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/07/26 | CA$0.3900 | -2.50% | 12,020 |
| 29/07/26 | CA$0.4000 | -4.76% | 7,099 |
| 28/07/26 | CA$0.4200 | +5.00% | 53,606 |
| 27/07/26 | CA$0.4000 | +6.67% | 76,066 |
| 24/07/26 | CA$0.3750 | +2.74% | 15,500 |
- Stock Market
- Stocks
- DTC Stock
Select your edition
All financial news and data tailored to specific country editions
